Related News
European shares tumble on grim data
By Brian Gorman |
April 6, 2009, Monday
|
Print Edition
Print Edition
EUROPEAN shares closed lower on Friday, with drug makers and oil firms falling, after unemployment and services-sector figures from the United States provided further evidence of recession.
The pan-European FTSEuro-first 300 index of top shares fell 1.3 percent to close at 771.6 points. The index rose 4.6 percent over the week, and is up 19.5 percent from its lifetime low on March 9.
The US economy lost 663,000 jobs in March, government data showed, compared with Reuters forecasts of 650,000. The unemployment rate is now 8.5 percent, in line with forecasts.
"After the euphoria of the G20, some economic reality has kicked in," said Philip Lawlor, chief portfolio strategist at Nomura, in London.
"We had a good run and some people have decided to lock profits in."
"The numbers weren't a huge shock, with the ADP data having given us a good steer on Wednesday," said David Evans, market analyst at BetOnMarkets.com.
There was worse news to come. Business activity in the US services sector shrank for a sixth straight month in March, compared with economists' forecasts for a rise.
As European bourses were closing, the Dow Jones, S&P 500 and Nasdaq Composite were down between 0.4 percent and 0.7 percent.
European drug makers were among the biggest losers.
AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Novartis and Roche were down between 2.4 percent and 4.6 percent.
The oil sector also retreated with crude prices down nearly 3 percent at just over US$51 a barrel.
BP, BG Group, Total, ENI and Statoil fell between 2.3 percent and 4 percent.
The pan-European FTSEuro-first 300 index of top shares fell 1.3 percent to close at 771.6 points. The index rose 4.6 percent over the week, and is up 19.5 percent from its lifetime low on March 9.
The US economy lost 663,000 jobs in March, government data showed, compared with Reuters forecasts of 650,000. The unemployment rate is now 8.5 percent, in line with forecasts.
"After the euphoria of the G20, some economic reality has kicked in," said Philip Lawlor, chief portfolio strategist at Nomura, in London.
"We had a good run and some people have decided to lock profits in."
"The numbers weren't a huge shock, with the ADP data having given us a good steer on Wednesday," said David Evans, market analyst at BetOnMarkets.com.
There was worse news to come. Business activity in the US services sector shrank for a sixth straight month in March, compared with economists' forecasts for a rise.
As European bourses were closing, the Dow Jones, S&P 500 and Nasdaq Composite were down between 0.4 percent and 0.7 percent.
European drug makers were among the biggest losers.
AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Novartis and Roche were down between 2.4 percent and 4.6 percent.
The oil sector also retreated with crude prices down nearly 3 percent at just over US$51 a barrel.
BP, BG Group, Total, ENI and Statoil fell between 2.3 percent and 4 percent.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
